NCT04994002View on ClinicalTrials.gov

A Pharmacokinetic, Pharmacodynamic, Safety and Tolerability Study of CERC-006 in Adults With Complex Lymphatic Malformations

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 3, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

June 30, 2022

Conditions
Lymphatic Malformation
Interventions
DRUG

CERC-006

Oral solution

Trial Locations (3)

30322

Children's Healthcare of Atlanta, Atlanta

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

80045

Children's Hospital Colorado, Aurora

Sponsors
All Listed Sponsors
lead

Avalo Therapeutics, Inc.

INDUSTRY

NCT04994002 - A Pharmacokinetic, Pharmacodynamic, Safety and Tolerability Study of CERC-006 in Adults With Complex Lymphatic Malformations | Biotech Hunter | Biotech Hunter